hypertension

Medtronic headquarters

Medtronic claims long-sought FDA approval in renal denervation

Medtronic claimed the FDA's second green light in renal denervation this month, as it competes with Recor for a potential multibillion-dollar market.

Conor Hale Nov 20, 2023 10:21am

Graphic of employees walking out depicting layoffs

Idorsia lays off 300 staff after previewing cost cuts in July

Oct 24, 2023 10:30am

visual of stethoscope and heart

Roche's bet pays off as Alnylam hypertension med hits in phase 2

Sep 7, 2023 8:55am

graphic art of a right hand signing something

Roche signs onto Alnylam's midstage hypertension med for $310M

Jul 24, 2023 11:00am

Stop sign

Windtree faces Catch-22 conundrum for hypertension med

Jul 5, 2023 8:11am

Mineral rock collection gem

Mineralys polishes $100M IPO ahead of phase 3 hypertension trial

Jan 19, 2023 9:10am